ID: ALA200261

Max Phase: Preclinical

Molecular Formula: C16H22NO8P

Molecular Weight: 387.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(NC(=O)OCc1ccccc1)P(=O)(O)CC(CCC(=O)O)C(=O)O

Standard InChI:  InChI=1S/C16H22NO8P/c1-11(17-16(22)25-9-12-5-3-2-4-6-12)26(23,24)10-13(15(20)21)7-8-14(18)19/h2-6,11,13H,7-10H2,1H3,(H,17,22)(H,18,19)(H,20,21)(H,23,24)

Standard InChI Key:  PBRHWMMNEISHGS-UHFFFAOYSA-N

Associated Targets(non-human)

UDP-N-acetylmuramoylalanine--D-glutamate ligase 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

UDP-N-acetylmuramoylalanine--D-glutamate ligase 1 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.33Molecular Weight (Monoisotopic): 387.1083AlogP: 2.09#Rotatable Bonds: 10
Polar Surface Area: 150.23Molecular Species: ACIDHBA: 5HBD: 4
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.55CX Basic pKa: CX LogP: 0.71CX LogD: -7.75
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.45Np Likeness Score: 0.25

References

1. Strancar K, Blanot D, Gobec S..  (2006)  Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD.,  16  (2): [PMID:16271472] [10.1016/j.bmcl.2005.09.086]

Source